Literature DB >> 17236749

Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications.

Robert K McNamara1, Ronald Jandacek, Therese Rider, Patrick Tso, Chang-Gyu Hahn, Neil M Richtand, Kevin E Stanford.   

Abstract

Previous studies have observed significant abnormalities in the fatty acid composition of peripheral tissues from drug-naïve first-episode schizophrenic (SZ) patients relative to normal controls, including deficits in omega-3 and omega-6 polyunsaturated fatty acids, which are partially normalized following chronic antipsychotic treatment. We hypothesized that postmortem cortical tissue from patients with SZ would also exhibit deficits in cortical docosahexaenoic acid (DHA, 22:6n-3) and arachidonic acid (AA; 20:4n-6) relative to normal controls, and that these deficits would be greater in drug-free SZ patients. We determined the total fatty acid composition of postmortem orbitofrontal cortex (OFC) (Brodmann area 10) from drug-free and antipsychotic-treated SZ patients (n=21) and age-matched normal controls (n=26) by gas chromatography. After correction for multiple comparisons, significantly lower DHA (-20%) concentrations, and significantly greater vaccenic acid (VA) (+12.5) concentrations, were found in the OFC of SZ patients relative to normal controls. Relative to age-matched same-gender controls, OFC DHA deficits, and elevated AA:DHA, oleic acid:DHA and docosapentaenoic acid (22:5n-6):DHA ratios, were found in male but not female SZ patients. SZ patients that died of cardiovascular-related disease exhibited lower DHA (-31%) and AA (-19%) concentrations, and greater OA (+20%) and VA (+17%) concentrations, relative to normal controls that also died of cardiovascular-related disease. OFC DHA and AA deficits, and elevations in oleic acid and vaccenic acid, were numerically greater in drug-free SZ patients and were partially normalized in SZ patients treated with antipsychotic medications (atypical>typical). Fatty acid abnormalities could not be wholly attributed to lifestyle or postmortem tissue variables. These findings add to a growing body of evidence implicating omega-3 fatty acid deficiency as well as the OFC in the pathoaetiology of SZ, and suggest that abnormalities in OFC fatty acid composition may be gender-specific and partially normalized by antipsychotic medications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17236749      PMCID: PMC1853256          DOI: 10.1016/j.schres.2006.11.027

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  82 in total

Review 1.  Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: implications for the pathophysiology and treatment of recurrent neuropsychiatric illness.

Authors:  Robert K McNamara; Michelle Ostrander; William Abplanalp; Neil M Richtand; Stephen C Benoit; Debbie J Clegg
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2006-08-28       Impact factor: 4.006

2.  Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging.

Authors:  J M Goldstein; J M Goodman; L J Seidman; D N Kennedy; N Makris; H Lee; J Tourville; V S Caviness; S V Faraone; M T Tsuang
Journal:  Arch Gen Psychiatry       Date:  1999-06

3.  Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics.

Authors:  L J Garey; K A Von Bussmann; S R Hirsch
Journal:  Exp Brain Res       Date:  2006-02-28       Impact factor: 1.972

4.  Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.

Authors:  C N Karson; R E Mrak; K O Schluterman; W Q Sturner; J G Sheng; W S Griffin
Journal:  Mol Psychiatry       Date:  1999-01       Impact factor: 15.992

5.  Selective increases in phosphoinositide signaling activity and G protein levels in postmortem brain from subjects with schizophrenia or alcohol dependence.

Authors:  R S Jope; L Song; C A Grimes; M A Pacheco; G E Dilley; X Li; H Y Meltzer; J C Overholser; C A Stockmeier
Journal:  J Neurochem       Date:  1998-02       Impact factor: 5.372

6.  Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects.

Authors:  Erik J Giltay; Louis J G Gooren; Arno W F T Toorians; Martijn B Katan; Peter L Zock
Journal:  Am J Clin Nutr       Date:  2004-11       Impact factor: 7.045

7.  Sub-chronic antipsychotic drug treatment does not alter brain phospholipid fatty acid composition in rats.

Authors:  Beth Levant; Jennifer F Crane; Susan E Carlson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-01-24       Impact factor: 5.067

8.  Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects.

Authors:  M Akil; J N Pierri; R E Whitehead; C L Edgar; C Mohila; A R Sampson; D A Lewis
Journal:  Am J Psychiatry       Date:  1999-10       Impact factor: 18.112

9.  Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.

Authors:  B M Ross; S Turenne; A Moszczynska; J J Warsh; S J Kish
Journal:  Brain Res       Date:  1999-03-13       Impact factor: 3.252

10.  Direct dopamine D2-receptor-mediated modulation of arachidonic acid release in transfected CHO cells without the concomitant administration of a Ca2+-mobilizing agent.

Authors:  C L Nilsson; M Hellstrand; A Ekman; E Eriksson
Journal:  Br J Pharmacol       Date:  1998-08       Impact factor: 8.739

View more
  45 in total

1.  Investigation of postmortem brain polyunsaturated fatty acid composition in psychiatric disorders: limitations, challenges, and future directions.

Authors:  Robert K McNamara; Ronald Jandacek
Journal:  J Psychiatr Res       Date:  2010-05-26       Impact factor: 4.791

2.  The fat-1 mouse has brain docosahexaenoic acid levels achievable through fish oil feeding.

Authors:  Sarah K Orr; Jasmin Y M Tong; Jing X Kang; David W L Ma; Richard P Bazinet
Journal:  Neurochem Res       Date:  2010-02-23       Impact factor: 3.996

Review 3.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 4.  Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology.

Authors:  Robert K McNamara; Jennifer J Vannest; Christina J Valentine
Journal:  World J Psychiatry       Date:  2015-03-22

5.  Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis.

Authors:  Robert K McNamara; Therese Rider; Ronald Jandacek; Patrick Tso
Journal:  Psychiatry Res       Date:  2014-01-02       Impact factor: 3.222

6.  Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: evidence for augmented biosynthesis.

Authors:  Robert K McNamara; Jessica A Able; Ronald Jandacek; Therese Rider; Patrick Tso
Journal:  Schizophr Res       Date:  2008-11-07       Impact factor: 4.939

7.  Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients.

Authors:  Ameer Y Taha; Yewon Cheon; Kaizong Ma; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Psychiatr Res       Date:  2013-02-18       Impact factor: 4.791

8.  Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species.

Authors:  Kei Hamazaki; Kwang H Choi; Hee-Yong Kim
Journal:  J Psychiatr Res       Date:  2010-01-06       Impact factor: 4.791

9.  A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression.

Authors:  Helen M Knight; Benjamin S Pickard; Alan Maclean; Mary P Malloy; Dinesh C Soares; Allan F McRae; Alison Condie; Angela White; William Hawkins; Kevin McGhee; Margaret van Beck; Donald J MacIntyre; John M Starr; Ian J Deary; Peter M Visscher; David J Porteous; Ronald E Cannon; David St Clair; Walter J Muir; Douglas H R Blackwood
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

10.  Semantic memory in schizophrenia: association with cell membrane essential fatty acids.

Authors:  Ruth Condray; Jeffrey K Yao; Stuart R Steinhauer; Daniel P van Kammen; Ravinder D Reddy; Lisa A Morrow
Journal:  Schizophr Res       Date:  2008-10-16       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.